Localisation of COX-2 protein is different in breast ductal carcinoma and adjacent non-tumour ductal epithelium
- 1 July 2005
- journal article
- research article
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 7 (6) , 239-243
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Cyclooxygenase 2 (COX2) expression is associated with poor outcome in ER‐negative, but not ER‐positive, breast cancerHistopathology, 2004
- The role of COX-2 inhibition in breast cancer treatment and preventionSeminars in Oncology, 2004
- Expression of cyclooxygenase-2 in malignant and benign breast tumors.2003
- Analysis of cyclooxygenase-2 expression in human breast cancer: high throughput tissue microarray analysisJournal of Cancer Research and Clinical Oncology, 2003
- Cyclooxygenase-2 expression is related to nuclear grade in ductal carcinoma in situ and is increased in its normal adjacent epithelium.2003
- Epidemiology of Non-Steroidal Anti-Inflammatory Drugs and Cancer2003
- Revision of the American Joint Committee on Cancer Staging System for Breast CancerJournal of Clinical Oncology, 2002
- Chemoprevention of gastrointestinal malignancies with nonsteroidal antiinflammatory drugsCancer, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Cancer statistics, 1998CA: A Cancer Journal for Clinicians, 1998